BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Duarte JA, de Barros ALB, Leite EA. The potential use of simvastatin for cancer treatment: A review. Biomed Pharmacother 2021;141:111858. [PMID: 34323700 DOI: 10.1016/j.biopha.2021.111858] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Duarte JA, Gomes ER, De Barros ALB, Leite EA. Co-Encapsulation of Simvastatin and Doxorubicin into pH-Sensitive Liposomes Enhances Antitumoral Activity in Breast Cancer Cell Lines. Pharmaceutics 2023;15:369. [DOI: 10.3390/pharmaceutics15020369] [Reference Citation Analysis]
2 Xu G, Xue W, Zhang D, Yu Z, Liu J, Zhao W. Non-targeted cellular metabolomics revealing the metabolomic features and anti-tumor mechanisms of cyanidin-3-O-arabinoside on Caco-2 cells. Food Bioscience 2022. [DOI: 10.1016/j.fbio.2022.102296] [Reference Citation Analysis]
3 Chen TC, Huang CW, Lo CY, Chen CN, Chang SF, Chen YY. Suppression of SREBP-1 Expression by Simvastatin Decreases Visfatin-Induced Chemoresistance to Sunitinib in Human Renal Carcinoma 786-O Cells. Life (Basel) 2022;12. [PMID: 36431025 DOI: 10.3390/life12111890] [Reference Citation Analysis]
4 Suterio N, Bazzo GC, Rauber GS, Silva AH, Caon T, Parize AL, Creczynski-pasa TB, Stulzer HK. Laponite® gel formulation containing simvastatin for melanoma treatment. Applied Clay Science 2022;228:106651. [DOI: 10.1016/j.clay.2022.106651] [Reference Citation Analysis]
5 Bartkowiak A, Nazaruk E, Gajda E, Godlewska M, Gaweł D, Jabłonowska E, Bilewicz R. Simvastatin Coadministration Modulates the Electrostatically Driven Incorporation of Doxorubicin into Model Lipid and Cell Membranes. ACS Biomater Sci Eng 2022. [PMID: 36173110 DOI: 10.1021/acsbiomaterials.2c00724] [Reference Citation Analysis]
6 Miyajima C, Hayakawa Y, Inoue Y, Nagasaka M, Hayashi H. HMG-CoA Reductase Inhibitor Statins Activate the Transcriptional Activity of p53 by Regulating the Expression of TAZ. Pharmaceuticals 2022;15:1015. [DOI: 10.3390/ph15081015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Zang H, Yang W, Tian X. Simvastatin in the Treatment of Colorectal Cancer: A Review. Evid Based Complement Alternat Med 2022;2022:3827933. [PMID: 35873646 DOI: 10.1155/2022/3827933] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Stepien K, Nowak K, Kachnic N, Horosin G, Walczak P, Karcinska A, Schwarz T, Wojtas M, Zalewska M, Pastuszak M, Wegrzyn B, Nessler J, Zalewski J. Statin Use in Cancer Patients with Acute Myocardial Infarction and Its Impact on Long-Term Mortality. Pharmaceuticals (Basel) 2022;15:919. [PMID: 35893743 DOI: 10.3390/ph15080919] [Reference Citation Analysis]
9 Kaulanjan K, Lavigne D, Saad F, Karakiewicz PI, Flammia RS, Kluth LA, Mandel P, Chun FK-, Taussky D, Hoeh B. Impact of Statin Use on Localized Prostate Cancer Outcomes after Radiation Therapy: Long-Term Follow-Up. Cancers 2022;14:3606. [DOI: 10.3390/cancers14153606] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Unnam S, Manjappa AS, Muddana Eswara BR, Salawi A, Gunti P. Liposomal Melphalan: Approach to obtain improved plasma stability, pharmacokinetics, and in vitro and in vivo anticancer efficacy in combination with liposomal simvastatin against mouse RPMI-8226 multiple myeloma model. Journal of Drug Delivery Science and Technology 2022;73:103479. [DOI: 10.1016/j.jddst.2022.103479] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Ahmad Malik J, Jan R, Ahmed S, Anwar S. Breast Cancer Drug Repurposing a Tool for a Challenging Disease. Drug Repurposing - Molecular Aspects and Therapeutic Applications 2022. [DOI: 10.5772/intechopen.101378] [Reference Citation Analysis]
12 Perkins EJ, Woolard EA, Garcia-reyero N. Integration of Adverse Outcome Pathways, Causal Networks and ‘Omics to Support Chemical Hazard Assessment. Front Toxicol 2022;4:786057. [DOI: 10.3389/ftox.2022.786057] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Saleem A, Akhtar N, Minhas MU, Mahmood A, Khan KU, Abdullah O. Highly Responsive Chitosan-Co-Poly (MAA) Nanomatrices through Cross-Linking Polymerization for Solubility Improvement. Gels 2022;8:196. [PMID: 35323309 DOI: 10.3390/gels8030196] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Whitlon DS. Statins and hearing. Hearing Research 2022. [DOI: 10.1016/j.heares.2022.108453] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Sambamoorthy U, Manjappa AS, Eswara BRM, Sanapala AK, Nagadeepthi N. Vitamin E Oil Incorporated Liposomal Melphalan and Simvastatin: Approach to Obtain Improved Physicochemical Characteristics of Hydrolysable Melphalan and Anticancer Activity in Combination with Simvastatin Against Multiple Myeloma. AAPS PharmSciTech 2021;23:23. [PMID: 34907484 DOI: 10.1208/s12249-021-02177-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
16 Mangelinck A, Habel N, Mohr A, Gaspar N, Stefanovska B, Fromigué O. Synergistic Anti-Tumor Effect of Simvastatin Combined to Chemotherapy in Osteosarcoma. Cancers (Basel) 2021;13:5869. [PMID: 34831022 DOI: 10.3390/cancers13225869] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
17 Meng X, Gao JZ, Gomendoza SMT, Li JW, Yang S. Recent Advances of WEE1 Inhibitors and Statins in Cancers With p53 Mutations. Front Med (Lausanne) 2021;8:737951. [PMID: 34671620 DOI: 10.3389/fmed.2021.737951] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]